Your browser doesn't support javascript.
loading
Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidence.
Santoni, Matteo; Iacovelli, Roberto; Colonna, Valentina; Klinz, Stephan; Mauri, Giorgio; Nuti, Marianna.
Affiliation
  • Santoni M; MD, U.O.C. Medical Oncology, Macerata Hospital, Macerata, Italy.
  • Iacovelli R; Medical Oncologist, Medical Oncology Unit, Fondazione Policlinico Agostino Gemelli IRCCS, Roma, Italy.
  • Colonna V; Global Medical Development Director, Global Oncology R&D, Ipsen S.p.A., Milano, Italy.
  • Klinz S; Senior Director, Translational Medicine & Biomarkers, Ipsen, United States, MA, USA.
  • Mauri G; Medical Advisor Oncology, Ipsen S.p.A., Milano, Italy.
  • Nuti M; Professor, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Expert Rev Anticancer Ther ; 21(9): 1029-1054, 2021 09.
Article in En | MEDLINE | ID: mdl-34445927
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Kidney Neoplasms / Liver Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Kidney Neoplasms / Liver Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United kingdom